Pfizer specific migraine treatment drug accelerates landing
Recently, Pfizer's new generation of specific migraine treatment drug, Rimezepam orally disintegrating tablets, has been approved for market by the National Medical Products Administration for on ...
Food and Medicine 2024-03-12